Renhe Pharmaceutical company intends to raise 918 million yuan to buy four shares

Renhe Pharmaceutical Industry (000650.　　SZ) Non-public offering of stock options announced today, the bulletin shows that the number of Non-public offering shares of not more than 50 million shares, the issue price is not less than 18.36 yuan/share, the total amount of funds proposed to raise not more than 918 million yuan. The announcement said that the collection of funds is mainly used for the acquisition of Jiangxi Pharmaceutical Capital Camphor Tree Pharmaceutical Group Co., Ltd. held Jiangxi drug all camphor Tree Pharmaceutical Co., Ltd. and Jiangxi Pharmaceutical Pharmaceutical Co., Ltd., through the expansion of the way to the Jiangxi Pharmaceutical Limited Liability company to implement restructuring, transformation, access to its 70% equity,　　Buy Renhe (Group) Development Co., Ltd. holds the Jiang Xiren and Medicinal Plastic Products Co., Ltd. 55% of the equity and buy Renhe Pharmaceutical Co., Ltd. and its subsidiaries jointly rented Ren (Group) Development Co., Ltd. office space.　　Renhe pharmaceutical Industry said that the investment project can enrich the product category, broaden the scope of business, through mergers and reorganization of high-quality enterprises, but also to achieve bigger, stronger, do excellent company's main business purposes. Renhe pharmaceutical business on February 23, suspended before the suspension, received 20.92 yuan.